Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ulinastatin Treatment Reduces the Incidence of Sepsis-associated Encephalopathy

NCT07090278 is registered in ClinicalTrials.gov with Shusheng Li as lead sponsor.

NCT NCT07090278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ulinastatin Treatment Reduces the Incidence of Sepsis-associated Encephalopathy
Lead sponsor
Shusheng Li
Phase
Observational
Overall status
Completed
Start date
January 1, 2019
Completion date
November 30, 2024
Enrollment
2,734 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis-associated encephalopathy